Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 1843 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regular (Ventas), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Pharmacien Qualité Produits H/F CDI, Full time | Development | France | Paris Headquarter (PHARMA) | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) CDI (Ventes), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regolare (vendite), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regular (Sales), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Kadrolu (Satış), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Redni sodelavec (prodaja), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) Regelmatig (Verkoop), Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Medical Representative, Solid Tumor (Tokyo or Nagano) 正式（销售）, Full time | Sales | Japan +Alternative Locations | Yokohama | Jan 22, 2026 |
| Global Program Safety Lead Regular, Full time | Development | Switzerland | Basel (City) | Jan 21, 2026 |
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting